Objective: Combined oral contraceptives (COCs) containing ethinyl-estradiol are known to increase blood pressure (BP). We evaluated whether COCs containing estradiol (E2) influence 24-h ambulatory BP and heart rate (HR) in normotensive and normal-weight women. Study design: Twenty-four-hour BP and HR were measured every 30 min with an ambulatory BP device in 18 normotensive healthy non-smoking women prior to (Days 3-6 of menstrual cycle) and after 6 months of use (Days 20-24 of cycle 6) of a COC containing either a quadriphasic combination of E2 valerate plus dienogest (n=11) or a monophasic association of micronized E2 plus nomegestrol acetate (n=7). Results: Mean age and body mass index of the final sample were 32.50±7.49 years and 22.87±4.08, respectively. E2-based COCs induced no modification of 24-h systolic BP (+1.65±8.34 mmHg; p=.41), diastolic BP (+0.04±7.36 mmHg; p=.98), mean BP (+0.64±6.42 mmHg; p=.68) or HR (-0.72±5.86 beats/min; p=.61). Differences were not observed even when daytime or nighttime values were separately considered. Though this was not a comparative study, we did not find differences between the effects of the two formulations (24-h mean BP; p=.699). Conclusions: These data suggest a neutral effect of estradiol-based COCs on independent risk factors for cardiovascular diseases such as BP or HR. Implications: BP and HR of normotensive women are not increased by E2-based COCs
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol / Grandi Giovanni; Xholli Anjeza; Napolitano Antonella; Piacenti Ilaria; Bellafronte Manuela; Cagnacci, Angelo. - In: CONTRACEPTION. - ISSN 0010-7824. - STAMPA. - 90(2014), pp. 529-534.
Titolo: | Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol |
Autori: | |
Data di pubblicazione: | 2014 |
Rivista: | |
Citazione: | Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol / Grandi Giovanni; Xholli Anjeza; Napolitano Antonella; Piacenti Ilaria; Bellafronte Manuela; Cagnacci, Angelo. - In: CONTRACEPTION. - ISSN 0010-7824. - STAMPA. - 90(2014), pp. 529-534. |
Abstract: | Objective: Combined oral contraceptives (COCs) containing ethinyl-estradiol are known to increase blood pressure (BP). We evaluated whether COCs containing estradiol (E2) influence 24-h ambulatory BP and heart rate (HR) in normotensive and normal-weight women. Study design: Twenty-four-hour BP and HR were measured every 30 min with an ambulatory BP device in 18 normotensive healthy non-smoking women prior to (Days 3-6 of menstrual cycle) and after 6 months of use (Days 20-24 of cycle 6) of a COC containing either a quadriphasic combination of E2 valerate plus dienogest (n=11) or a monophasic association of micronized E2 plus nomegestrol acetate (n=7). Results: Mean age and body mass index of the final sample were 32.50±7.49 years and 22.87±4.08, respectively. E2-based COCs induced no modification of 24-h systolic BP (+1.65±8.34 mmHg; p=.41), diastolic BP (+0.04±7.36 mmHg; p=.98), mean BP (+0.64±6.42 mmHg; p=.68) or HR (-0.72±5.86 beats/min; p=.61). Differences were not observed even when daytime or nighttime values were separately considered. Though this was not a comparative study, we did not find differences between the effects of the two formulations (24-h mean BP; p=.699). Conclusions: These data suggest a neutral effect of estradiol-based COCs on independent risk factors for cardiovascular diseases such as BP or HR. Implications: BP and HR of normotensive women are not increased by E2-based COCs |
Handle: | http://hdl.handle.net/11390/1105750 |
Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
Contraception E-BP2014.pdf | Versione Editoriale (PDF) | Non pubblico | Accesso ristretto Richiedi una copia |